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                              INTRODUCTION 
        Breast cancer is the second most common cancer in females world 
wide accounting for about 1.4 million cases each year, with more than 
half of the deaths due to breast cancer occurring in low and middle 
income countries. Breast cancer is the second leading cause of cancer 
related deaths in females all over the world
66
. Breast cancer have doubled 
in India in the last two decades.  
         The number of women estimated to be dying of breast cancer every 
year has also been steadily raising. As against an estimated 48,170 
women who died of breast cancer in 2007, the number reached the 50,000 
in 2010,which raised to 50,821 by 2011.An ICMR study in many 
cosmopolitan cities like Chennai revealed that the incidence of cervical 
cancer had been dropped  and breast cancer incidence were emerging. 
Between 2006-2008 the incidence of breast cancer in Chennai was 
26.5%(ICMR).As per study conducted in Coimbatore, percentage of 
occurrence of breast cancer was found to be 20.3out of 1 lakh women.  
        Fine needle aspiration cytology is being increasingly used to 
determine the benign and malignant nature of the lesion. This also 
provides additional information about the intrinsic nature of the lesion 
and the prognosis
12
.Attempts have been made to determine various 
prognostic parameters on FNA Material to determine the best therapy in a 
given case 
68,69
. Due to its tremendous increase in incidence rates, it is 
desirable to grade the tumor while is still in vivo for the selection of 
appropriate therapy and to avoid overtreatment for low grade carcinoma.  
            The significance of histological grading was accepted .It was also 
found to be a useful supplementary prognostic parameter .So when a 
significant association was established between cytologic and histologic 
grading systems, cytologic grading may be helpful to decide the level of 
treatment.  
  
                           
AIM  OF THE STUDY 
  
        To evaluate the cytological grading by Robinson method in FNAC 
samples and to correlate it with the well known prognostic factor, 
Histological grading system proposed by Nottingham Modification of 
Bloom Richardson .The cytologic grading system was also correlated 
with the axillary lymph node status.  
  
OBJECTIVE  
1. To grade the cytological features of the fine needle aspirates of         
ductal carcinoma of breast 
2. To grade the histomorphological features of invasive duct 
carcinoma in mastectomy specimens 
3. Correlate statistically the cytological grading system with 
histological grading system. 
  
REVIEW OF LITERATURE 
 
 Breast carcinoma is the second most common malignant tumor  in 
females, with more than 100,000 cases occurring worldwide annually
2
. 
As per datas given by the World Health Organization there are 7.6 
million cancer deaths per year all over the world, out of which 5,02,000 
are due to breast cancer alone. With such an increased rate, breast cancer 
is one of the most fatal cancers. The incidence is high in North America 
and North Europe (91.4 new cases per 100,000 women / year) 
intermediate in southern and latin American countries and low in Asian 
and  African countries
2
.It can occur at any age, but the peak  incidence  is 
45-60 years. The frequency is increasing in younger age groups and this 
is not due entirely to an increase in “at risk” population. Breast carcinoma 
is 20 times more common in women than men. Affected males tend to be 
somewhat older.  
            Wani et al reported that, In India breast is reported as the most 
common site of cancer in Mumbai and Thiruvanandapuram, second most 
common site in Chennai and dibrugarg
18
. The most common tools used 
for diagnosis are mammography and a fine needle aspiration biopsy 
(FNA). Mammography is a non-invasive method, used for screening 
purposes rather than for precise diagnosis.A fine needle aspiration biopsy 
is an invasive method to obtain a small sample of the breast tissue that 
allows the pathologist to diagnose the type of the cancer in detail. 
 
ANATOMY OF BREAST: 
      The adult mammary gland is a compound tubulo -alveolar gland. 
The mammary gland is covered with skin and subcutaneous tissue and 
rests on pectoralis muscle, from which it is separated by a fascia.  
          The functional unit of breast is composed of two major parts: 
Terminal duct lobular unit (TDLU) and larger duct system. The TDLU is 
formed by the lobule and terminal ductule and represents the secretory 
portion of the duct. 
 
HISTOLOGY OF BREAST: 
            A Glandular lobule consists of intralobular ducts surrounded by 
loose intralobular connective tissue that contains fibroblast, lymphocytes 
and plasma cells. Intralobular ducts are lined by a specialized two layered 
epithelial cells; cuboidal to low columnar epithelial cells and basal 
myoepithelial cells. Lobule is surrounded by dense interlobular 
connective tissue which contains a large interlobular duct.     
CYTOLOGY IN LESIONS OF  BREAST: 
       Fine needle aspiration cytology is a valuable tool in the work up of 
all breast abnormalities, both palpable and non palpable. Fine needle 
aspiration cytology of breast was first used in 1930 by Mortan Ellis and 
Stewart. It was increasingly used for the preoperative diagnosis of breast 
carcinoma
4
. 
        FNAC has a sensitivity of 87%, specificity of 99%, negative 
predictive value of  99%
7,8,9
.
 
The false negative rate of only 10% has been 
reported 
8,9
. The percentage of inadequate specimens should be always 
less than 10%
10
.The false positives are always interpretation errors. The 
diagnostic accuracy of FNAC is defined as a correlation with histologic 
findings, depending on the availability of a good aspirate and good 
abilities of reporting
14
. One of the major drawbacks of this technique is 
obtaining an insufficient specimen.  
      The NCI guidelines recommend the use of 22-23 gauge needle aimed 
at the central portion of the tumor and moved at different directions. For 
fibrotic and necrotic lesions needle should be aimed at the periphery of 
the tumor. There were no strict requirements for the number of ductal 
epithelial cells to be present for sample to be adequate. Adequacy can be 
determined by the aspirator and the pathologist who examine the slide. 
           
        The NCI conference proposed to classify the cytological features 
into the following categories: 
 benign 
 atypical/indeterminate 
 suspicious/indeterminate 
 suspicious/probably malignant 
 malignant  
 unsatisfactory 
 The guidelines emphasizes to include the microscopic findings that are  
specific for each category. 
          The FNAC procedure induce histologic changes of the lesions 
which includes extensive necrosis, epithelial displacement and 
hemorrhage with or without organization. Needle tract seedling has not 
been reported with breast cancer. The advantage of FNAC in breast 
lesions lies in the precise diagnosis, minimal or no morbidity and good 
patient acceptance. 
 
INVASIVE DUCT CARCINOMA : 
             Invasive duct carcinoma is the group of malignant tumors of the 
breast which have the tendency to invade the adjacent normal breast 
tissues and also the distant organs. They can be classified into various 
histological types. Invasive duct carcinoma Not otherwise specified 
(NOS) is the most common type. Various terms have been used to 
describe such tumors, including Ductal carcinoma, Carcinoma not 
otherwise specified and invasive carcinoma of no special type. For the 
present time, the preferred nomenclature accepted by WHO is Invasive 
duct carcinoma ,no special type .This comprises about 75-80% of breast 
carcinoma
25,26
.This also includes tumors that express in part one or more 
characteristics of the specific types of breast carcinoma but do not 
constitute the pure examples of the individual tumors. 
           The relatively favourable prognosis associated with some special 
types has been found to apply only to those tumors composed entirely or 
large proportion by the specific pattern .When these features are less 
extensively represented, the prognosis depends on the broader group of 
Invasive duct carcinoma NOS. Tumors combining features of invasive 
duct carcinoma with pagets disease are classified as Invasive duct 
carcinoma. Approximately one third of the lesions characterized as 
Invasive duct carcinoma NOS has one or more of the combined features. 
More than half of the combined tumors were ductal carcinoma with 
tubular carcinoma component. Combinations with invasive lobular 
carcinoma were detected in 6% of lesions. There is a significant 
correlation between the grade of the intraductal and invasive component 
in those tumors that have both components.This indicate that the 
prognosis of the tumor can be assessed in the preinvasive stage itself. The 
tumor can arise anywhere in the breast, the most common site being outer 
and upper quadrant. 
              The main presenting complaint in breast carcinoma is palpable 
breast lump. They vary in size from one to several centimeters in 
diameter, are firm to hard and the edge may be well or poorly defined. 
About 2 percent of the patients present with the synchronous bilateral 
tumors. Nipple discharge is an infrequent presenting sign and the breast 
pain is very rarely a manifestation of malignancy. In the recent days, the 
introduction of mammographic breast screening has changed the pattern 
of presentation .In the target age group many cases are detected because 
of mammographic screening which detects impalpable mammographic 
abnormality 
           FNAC in most of the Invasive duct carcinoma gives a high yield 
than the normal breast tissue.The only exception was schirrous carcinoma 
where it gives a scanty aspirate.Morphologic classification of breast 
cancer was also done in FNAC specimens.  Based on the 
cytomorphological criteria proposed by World Health Organization , 254 
various histologic types of invasive breast carcinoma can be diagnosed . 
This morphological classification has some impact on the prognosis. 
Certain subtypes has favourable prognosis which includes pure mucinous 
(colloid), true medullary, tubular carcinoma, adenoid cystic carcinoma, 
papillary carcinoma, and secretory carcinoma whereas certain subtypes 
have unfavourable prognosis which includes metaplastic carcinoma, 
inflammatory carcinoma, pleomorphic lobular carcinoma. 
            As per the American Cancer Society, about two-thirds of women 
with an invasive duct carcinoma NOS are 55years or older. The overall 
survival rate is 55-65%. 
 
DIAGNOSTIC CRITERIA FOR DUCT CARCINOMA IN 
CYTOLOGY: 
 Cellular smear 
 Malignant epithelial cells arranged in three-dimensional clusters,           
syncytium, and acini 
 Single population of cells 
 No myoepithelial cells; no bare or bipolar nuclei 
 Moderate to severe nuclear atypia 
 Uneven necrosis 
 Tumor diathesis may be present 
 Some cases demonstrate cytolpasmic vacuolation or intracellular 
lumina 
CRITERIA SUGGESTIVE OF INVASIVE LESION IN 
CYTOLOGY: 
 Proliferation of fibroblast 
 Cell poor elastoid stromal fragments 
 Single cells or small clusters of cells in stromal tissue and fatty  
fragments                     
 Tubular structures 
 Intracytoplasmic vacuoles      
 
HISTOPATHOLOGIC FEATURE IN INVASIVE DUCT 
CARCINOMA NOS: 
        Invasive duct carcinoma NOS is a diagnosis of exclusion and there 
are no specific morphological features and a variety of histological 
appearance may be seen. These include tumors which do not satisfy the 
criteria necessary to qualify for any other special types 
           Gross: Firm to hard, poorly circumscribed, gritty to cut, trabaculae 
extending to surrounding parenchyma. The size may vary from 0.5-10cm 
         Microscopy: Tumor arranged in diffuse sheets, well defined nest, or 
as individual cells, nuclei may be regular or large pleomorphic with 
prominent nucleoli.Mitotic figures may be seen depending on the grade 
of the tumor. The stroma may be densely fibrotic to highly cellular. To be 
typed as Invasive duct carcinoma NOS, 90% must be composed of that 
type. If the Invasive duct NOS comprises between 50-90%,then it will be 
classified as mixed type. In most cases areas of associated DCIS and 
occasionally areas of squamous metaplasia may be seen. Some shows 
foci of neuroendocrine differentiation. 
 
OTHER SPECIAL TYPES: 
TUBULAR CARCINOMA: 
          The frequency of tubular carcinoma is 1-3 %.Tubular carcinoma is 
widely recognized to have an excellent prognosis.           
          Cytology: Low to moderately cellular smears, predominately in 
cohesive clusters, angulated rigid open tubules and glands with comma 
shaped projections. Mild to moderate nuclear atypia made out. This is one 
of the tumor which is under diagnosed due to the relatively monomorphic 
appearence of the tumor cells with mild atypia. 
          Gross: Pure tubular carcinoma is relatively small, usually measures 
between 2mm and 1.5cm in diameter, most of them are less than 1 cm in 
diameter. Two morphologic subtypes are encountered they include “pure” 
subtype in which stellate nature is pronounced and “sclerosing” subtype 
where it is diffuse and more ill defined 
         Histopathology: Well differentiated neoplasm with irregular 
angulated tubules with open lumina lined by only one layer of epithelial 
cells with mild pleomorphism. The stroma is abundant and cellular.The 
nucleus show little pleomorphism with rare mitoses. For a tumor to be 
typed as tubular carcinoma , tubular morphology should comprise >90% 
of its area. If less than 90%,  it is classified as the mixed type. But for the 
combination of tubular and cribriform carcinoma, that tumor is classified 
as tubular, if the tubular pattern comprises > 50% of the tumor area.   
 
MUCINOUS CARCINOMA: 
      The frequency of the tumor ranges from 1-4%.It has a better survival 
rate compared to the usual infiltrating ductal carcinoma of breast. This 
type is also referred to as colloid carcinoma. These are tumors in which 
mucin production is apparent to naked eye. These comprises only tumors 
entirely composed of mucinous patern, owing to its favorable prognosis. 
     Cytology:  Aspirate yields a gelatinous material. Atypical cells 
arranged in solid clusters or single files with moderate degree of nuclear 
atypia in a background of abundant mucin. 
       Gross: Well circumscribed tumor mass with a soft consistency and a 
glistening gelatinous cut surface.The size may vary from 1-4cm 
      Histopathology:  Small clusters of regular epithelial cells floating in a 
pool of extracellular mucin .The cells are small with darkly staining 
nuclei which exhibiting mild pleomorphism. Mitoses are infrequent. 
 
MEDULLARY CARCINOMA: 
     The reported frequency varies between 2-10 percent. 
    Cytology: Highly cellular smears with poorly cohesive cells, large 
pleomorphic nuclei and many lymphocytes and occasional plasma cells. 
The false negatives can be reduced by careful search of malignant 
epithelial cells in the aspirates with increased number of lymphocytes in 
the background . 
    Gross:  Well circumscribed tumor with pushing margins, with a soft 
and uniform consistency, usually measuring between 1-4 cm 
     
Histopathology:  
Three main morphologic criteria for diagnosis of medullary carcinoma 
1. Epithelial cells arranged in interconnecting sheets forming a syncytial 
network. Syncytial pattern of growth comprise >75% of tumor. Tumor 
cells are large pleomorphic with prominent nucleoli and high mitotic rate. 
2.The intervening stroma contains lymphoplasmacytic infiltrate. 
3. Grossly evident circumscription, border of the tumor is pushing rather 
than infiltrative. 
 
ATYPICAL MEDULLARY CARCINOMA: 
             Features of typical medullary carcinoma but no more than two 
atypical features. The atypical features include infiltrating margins, 
absent or mild lymphoplasmacytic infiltration, uniform nuclei, focal 
tubule formation and presence of in situ carcinoma.  
 
MICROPAPILLARY CARCINOMA:  
        Invasive micropapillary carcinoma is a recently diagnosed variant 
of Invasive duct carcinoma 
 
 
 
Cytology:  
 Cellular smears 
 Cells arranged in multilayered sheets, rounded aggregates with 
distinct anatomical borders without a stromal core. 
 Individual cells are cuboidal to columnar with moderate nuclear 
atypia. 
     Histopathology: Cluster of epithelial cells arranged in a 
micropapillary or tubular-alveolar pattern without a fibrovascular core 
suspended in a clear space. Cell clusters appear to have an inside out 
appearance. This tumor has an increased incidence of vascular invasion 
and lymph node involvement .It has a poor prognosis. 
 
PAPILLARY CARCINOMA: 
         It constitutes <1% of symptomatic cases. It is frequent in elderly. 
         Cytology: 
 Highly cellular smear 
 Complex branching papillae with thin fibrovascular 
core  
 Papillae lined by multilayered epithelial cells 
 Marked discohesion  
 Tall columnar cells 
 Malignant epithelial cells with nuclear atypia and 
enlargement 
 No myoepithelial cells 
 Background shows blood and hemosiderin-laden 
macrophages 
         Gross: Most of the tumors are well demarcated, soft in consistency , 
measure between 1-3 cm. 
         Histopathology:Presence of papillary structures with  fibrovascular  
cores. Cytologic appearance may be varied. Nuclear pleomorphism and 
increased mitosis may be seen. 
 
 SECRETORY CARCINOMA : 
         These tumors are described in children, but are now known to occur 
in adults of all ages. Secretory carcinoma of the breast was first described 
by McDivitt and Stewart in 1966.It is one of the rarest tumors. 
           Cytology: Loose aggregates of malignant epithelial cells with 
abundant granular, eosinophilic vacuolated cytoplasm and a relatively 
bland nuclei.  
           Gross: Well circumscribed tumor, usually less than 2 cm in 
diameter. 
          Histopathology: Tumor islands of irregular tubules containing 
eosinophilic material. Cells have abundant pale staining cytoplasm with 
nucleus showing mild pleomorphism. Tumor shows a well circumscribed 
border with peripheral fibrosis. The diagnostic feature is the presence of 
intra and extracellular rounded vacuoles giving a overall clear cell 
pattern.The individual cells show mild nuclear pleomorphism with 
infrequent mitoses.These vacuoles stain positive for Alcian blue and PAS 
with diastase resistant. 
 
APOCRINE CARCINOMA: 
Invasive duct carcinoma show focal areas of apocrine metaplasia. 
But tumors composed entirely of apocrine cells are less frequent.The 
prognosis of these tumors were similar to that of invasive duct carcinoma 
NOS. 
 
METAPLASTIC CARCINOMA:  
           Metaplastic carcinoma is characterized by a mixture of  ductal 
carcinoma with areas of spindle, squamous, chondroid, or osseous 
metaplasia 
            Cytology: Tumor with malignant ductal cells and spindle cells. 
Multinucleate giant cells may be seen. The sarcomatoid component is 
usually malignant spindle cells and in some cases it may show 
osteosarcomatous or chondrosarcomatous differentiation 
            Gross: Large, firm nodular tumors usually more than 5cm in 
diameter. Tumor is fixed to deep fascia. 
            Histopathology: Malignant ductal carcinoma which in addition to 
epithelial elements show transtition to sarcomatous elements including 
cartilage, bone, myxoid stroma and spindle cell stroma. The most 
common metaplastic component is malignant spindle cells.There are two 
types: monophasic sarcomatoid and biphasic sarcomatoid. More than one 
sarcomatous component can be seen. It is difficult to assess the prognosis 
of metaplastic carcinoma because of its rarity, but available evidence 
suggests that these tumors behave as a highly malignant tumors with 
early recurrence and poor survival. 
 
CARCINOMA WITH NEUROENDOCRINE DIFFERENTIATION: 
         Cytology: Cell rich smears of numerous dispersed small uniform 
cells with a coarse granular chromatin. 
         Histopathology: Small tumor cells arranged in solid nest separated 
by fibrous stroma. Tumors with neuroendocrine differentiation is found to 
have an improved prognosis 
 
LOBULAR CARCINOMA: 
         The classical form of lobular carcinoma was first described by 
Foote and Stewart. 
         Cytology: Smears have a scant cellularity. Cells arranged in small 
clusters and single files .Individual cells are small round uniform with 
hyperchromatic nuclei and scant cytoplasm. Intracytoplasmic lumina, 
mucin vacuoles, nuclear moulding and signet ring cells may be present, 
No bipolar nuclei are seen in the background. 
         Histopathology: Classic variant: Small uniform cells growing in a 
single file and in a concentric fashion around the lobules. The stroma is 
abundant and fibrous. The individual cells are small round to ovoid with 
little cytoplasm with eccentrically placed nucleus exhibiting mild 
pleomorphism and infrequent mitoses. 
 
 
Other variants include: 
                 Alveolar: Cells similar to classic type arranged in aggregates of 
20 or more cells. 
                 Solid: Cells infiltrate diffusely in sheets rather than cords with 
little intervening stroma. 
                Tubulolobular: Cells arranged in cords and tubules. These 
tubules are much smaller than that of tubular carcinoma. 
                 Pleomorphic: Classical lobular infiltrative pattern with cells 
exhibiting cellular atypia and nuclear pleomorphism. These cells have 
more eosinophilic cytoplasm. 
 
MIXED TYPES: 
           The mixed ductal and lobular comprises of tumors in which the 
ductal component constitutes between 10 and 90 percent of the tumor. 
The mixed ductal and special type include any tumors composed of 
mixture of tubule-lobular, tubular,cribriform or mucinous carcinoma with 
ductal NOS in which the later forms over 10 percent of the tumor. 
 
PROGNOSTIC FACTORS ON CYTOLOGIC SAMPLES OF 
DUCTAL CARCINOMA OF BREAST: 
             In recent years attempts have been made to determine the various 
prognostic parameters on FNA material for management. Evaluation of 
prognostic factors is helpful in the decision of preoperative neoadjuvant 
chemotherapy in high grade tumors, avoidance of conservative surgery in 
high grade tumors and usage of specific treatment modalities like 
Tamoxifen ,herceptin. The various prognostic factors that can be 
evaluated in cytological samples include tumor grade, estrogen receptor 
status and proliferative activity  
                Jayaram et al
11
 states that of the various prognostic factors, 
tumor type, tumor grade, receptor status and cellular proliferative rate are 
the important prognostic factors that can be validated at cytological level. 
Among these tumor grade is the easy, feasible, assessable and cost 
effective prognostic factor 
11
 
 
CYTOOGICAL GRADING SYSTEM IN DUCTAL CARCINOMA 
OF BREAST: 
            The National cancer Institute (NCI) Bethesda, sponsored 
conference had also recommended that tumor grading on FNA material 
should be incorporated in FNA reports for prognostication
13.
 It was 
emphasized that grading system used in cytological samples should 
correspond to the grading system used in histological specimen. 
            Wani et al
18
 had stated that grading of breast carcinoma, when the 
tumor is still in vivo, would be the best and desirable method, because it 
would be helpful for the selection of appropriate therapy.Preoperative 
cytological grading will give an indication for presumed aggressiveness 
rather than therapeutic implication. Various grading systems were 
introduced in cytological samples. They include Black’s nuclear grading 
system which is a two tier grading system, which differentiates  into low 
grade and high grade carcinoma
36,37. 
 
           Then the Fishers modification of Blacks grading system which is a 
three tier grading system which grades into well differentiated, 
moderately differentiated and poorly differentiated grade
15,16
. Howell et 
al. attempted to grade the cytological features of breast carcinoma using 
Elston and Ellis-modification of the Scarff–Bloom–Richardson grading 
system .But this attempt is of little success due to difficulties in assessing 
tubule formation and counting mitosis in cytologic smears. 
          The other grading system used were Masood cytological grading 
system and Hunt’s grading system. Of the various grading systems, 
Robinson and  Mouriquand corresponds to the histological grading  by 
the Nottingham modification of Scarff Bloom Richardson method .The 
diagnostic accuracy and sensitivity of both Robinson and Moriquand 
grading systems were similar.However the specificity of Moriquand 
system was quite low
17
. However Robinson grading system has been 
found to be easier and better because of more objective set of criteria and 
reproducibility 
18
.In a study by Bhargawa et al comparing Robinsons’ 
method of cytological grading, Fischer modification of Black’s nuclear 
grading, Scarff bloom Richardson grading on cytological samples, 
Robinson method showed a good correlation with histological grading. 
          In a study by Rekha et al, various special types like colloid 
carcinoma, tubular carcinoma and lobular carcinoma and medullary 
carcinoma were also graded using cytological grading system by 
Robinson method
19.
A study by Khan MZ et al have also graded certain 
special types of ductal carcinoma which includes tubular, medullary, 
papillary and lobular carcinoma. Because nuclear grading does not 
involve an assessment of the growth pattern of the tumor, it applies to 
other subtypes of breast carcinoma also. 
          The Robinson method of cytological grading system include the 
following factors: Cell dissociation, cell uniformity, nuclear size, 
chromatin pattern, nucleoli, nuclear membrane. Among various factors 
cell dissociation, chromatin pattern and presence of nucleoli were the 
most significant factors
20
.  They also found that cell uniformity and 
nuclear margins corresponds to the nuclear pleomorphism in histologic 
grading .So these parameters are given more importance since tubule 
formation and mitotic rate were difficult to analyze in cytological 
samples. This is the reason why Scarff Bloom Richardson grading system 
cannot be applied on cytologic samples. Nuclear grading can be 
performed in May Grunwald Geimsa,  papanicolaou  and  H&E stained 
smears. In a study by Idris et al papanicolaou stain showed the good 
quality of staining with a high quality index of 0.87, next ranked the    
H& E stain with a quality index of 0.81, followed by MGG stain with a 
low quality index
21
.Pap stain is advantageous over other stains as it stains 
the nuclear chromatin well and gives a good differential cytoplasmic 
counterstaining.  
 
PROGNOSIS IN INVASIVE DUCTAL CARCINOMA OF BREAST 
           Breast carcinoma is a heterogeneous disease clinically, 
pathologically, radiologically and differs in its biological potential. As 
noted by Sistrunk and Mc carty, It is impossible to foster the duration of 
life of patients with carcinoma of the breast, because the degree of 
malignancy varies widely and patients react differently to the disease
22
. In 
a report by Heilmann and Helmann
22
, risk of recurrence and time of 
recurrence depends on tumor size and nodal status
23.  
             In a similar type of analysis by Blamy et al
24
, tumor grade was 
assessed with risk and time of recurrence. They observed that 90% 
recurrence occurred within 9,7and 5 years with grade 1,2and 3
24
.The rate 
of death due to breast carcinoma was also influenced by tumor grade with 
90% occuring in 40,13 and 8 years in grade 1,2and 3 tumors. The study 
by Blamey et al also states that histologic grade proved to be an 
additional determinant of metastagenicity and virulence of tumors. 
 
TUMOR SIZE: 
       For prognostic  purposes the size of the tumor should be evaluated by 
the pathologist, as clinical measurement is not sufficiently required.  The 
measured gross size, which is represented by the largest diameter of the 
tumor  is one of the most significant variable. Tumor size and lymph node 
status are two independent prognostic variables
27,28,29
. Datas from the 
breast cancer surveillance consotorium for 786,846 women ages 40-89 
years with breast carcinomas  revealed negative axillary node metastasis 
in 91.8%,78.2%,57.9% of patients with tumor size measured 0-10mm,11- 
20 mm,21-50mm  respectively 
30
.Queit et al states that the disease free 
survival after mastectomy was 81% in tumors <2cm and 59% in tumors 
>2cm 
31
.Tumors less than 10 mm in diameter are called the minimal 
invasive carcinoma, which represent the earlier stage of the disease. 
Recommendations for measuring the tumor size:  
1. Tumor should be measured in all three dimensions to the nearest 
millimeter before fixation. The measurement are checked after 
fixation and the single largest dimension should be taken into 
account. 
2. For tumors less than 10mm and for cases in which there is large 
in situ component, microscopic assessment of tumor size using 
stage micrometer is accurate. 
3. When both in situ and invasive components are seen, 
measurement of invasive component is taken into account, in 
such cases microscopic assessment of tumor size is more 
accurate. 
4.   For multifocal and multicentric lesions are seen, size of the 
largest invasive lesion is considered 
          In Nottingham/Tenovus study, tumor <15 mm in size confer a good 
prognosis with favourable clinical outcome
2
.So the cut off point for long 
term survival is 15mm. Furthermore the Nottingham /Tenovus Primary 
Breast Cancer Study has confirmed by multivariate analysis that tumor 
size is an significant independent variable forming an integral component 
of Nottingham Prognostic index
33,34
 
LYMPH NODE STATUS: 
        Axillary lymph node status is an important indicator of systemic 
adjuvant therapy.It is based on the histological examination of excised 
nodes rather than clinical examination. Nodal metastasis are divided into 
three categories based on size .Numerous studies have shown that 
patients with positive loco-regional nodes have poor prognosis when 
compared to those without nodal involvement
33,35
.  
 Prognosis also depends on the number and level of regional nodes 
involved..The greater the number of nodes involved poorer the 
prognosis
36,37 
.Nodes in the higher or more distal levels of axilla carries a 
worse prognosis
38,39.
High axillary clearance usually shows increased 
morbidity. The introduction of sentinel node biopsy with or without 
additional node sampling resulted in reduced use of axillary clearance. 
Low axillary clearance ,below the intercostal nerve produces sufficient 
lymph nodes (4-15) for accurate prognstication . 
Lymph node metastasis is divided into three categories based on the size       
                  >2 mm- macrometastasis 
                   0.2-2mm-micrometastasis 
                  <0.2mm- isolated tumor cell and tumor cell clusters 
Lymph node stage is divided into three categories as follows 
                  PN1-1-3 nodes 
                  PN2-4-9 nodes 
                  PN3->10 nodes 
Recommendation for analysis of lymph node status : 
1. Every lymph node obtained should be examined histologically. 
2. Grossly uninvolved nodes are submitted as a whole where as only 
representative sections of the involved nodes are submitted. 
3. Histopathology report should include total number of enlarged 
lymph nodes, number of positive lymph nodes and the greatest 
dimension of largest metastatic node and extranodal extension. 
4. Lymph nodes under 5mm can be bisected and blocked. 
5. Lymph nodes >5mm should be sliced at 2-3 mm intervals 
perpendicular to long axis. 
               Jean. F.Simpson states that even though lymph node is the most 
important predictor of prognosis, lymphnode status alone is not sufficient 
for treatment decision to be made
40
 
 
 
TUMOR CONFIGURATION: 
            Tumors with circumscribed margins have a better prognosis than 
tumors with infiltrative margins. Infiltrative tumors tend to be larger and 
likely to have axillary node metastasis
41,42
.Tumors with stellate 
configuration with focal necrosis have poor prognosis 
42
 
 
HISTOLOGIC TYPE: 
          The favourable prognosis of certain histologic subtypes of invasive 
carcinomas is now well recognized. Patients with invasive duct 
carcinoma of breast can be divided into broad prognostic factors 
according to histologic type: 
Excellent prognosis: Tubular, cribriform, mucinous and tubulolobular 
carcinoma  
Good prognosis: Mixed- tubular, Mixed- ductal NOS and special type 
and classic lobular carcinoma 
Average prognosis: Mixed lobular, medullary and atypical medullary 
carcinoma 
Poor prognosis: ductal NOS,mixed ductal and lobular, solid lobular 
carcinoma and grade 3 basal type carcinoma 
LYMPHOVASCULAR  INVASION: 
 1. Tumor emboli in clear spaces with endothelial lining. 
 2. Tumor emboli do not assume the same shape as the lymphovascular 
vessel.     
           Lymphovascular invasion is specifically of prognostic value in 
node negative disease and predicts local recurrence after breast 
conservation surgery
64
 and flap recurrence following mastectomy
65
. 
 
HISTOLOGIC GRADE: 
           The essential aspect of oncologic pathology has been the 
recognition that the morphological appearance of tumors can be 
correlated with the grade of malignancy
58
. 
            In 1925 first analysis in breast carcinoma was carried out by 
Greenhough who classified into three grades based on eight histological 
factors. In 1928 Scarff and Patey reassessed and found that tubule 
formation, hyperchromatic figures and regularity in size and shape of 
nuclei were the three important factors .                           
           In 1950 Bloom favoured greenhough method and used the three 
factors- degree of tubule formation,regularity in size and shape of nuclei 
and mitotic figures. In 1957 Bloom and Richardson developed the 
grading system in the form of numerical scoring system.In 1968  Patey 
and Scarff method along with Bloom Richardson method has become the 
Bloom Richardson grading Method
58
. 
            In 1982 Elston modified the Scarff Bloom Richardson method to 
improve the assessment of mitotic figures. In 1991 Nottingham improved 
the objectivity of histological grading for assessment of each component 
factor.  Leslie et al states that histologic grading of invasive breast cancer 
is a valuable prognostic feature. It is a simple low cost method which 
serves to evaluate morphological characteristics semiquantitatively. 
          Jean.F.Simpson et al states that the Nottingham Combined 
Histologic Grade (NCHG) system is a modification of the Scarff-Bloom-
Richardson  grading system,which combines the analysis of glandular 
differentiation, nuclear grade, and mitotic activity
40
. The NCHG has been 
shown to be predictive
 
and reproducible and is in widespread use
43,44
. 
        John s.Meyer et al state that most useful components of grading 
system which assess the prognosis are mitotic index and tubularity. The 
Nottingham–Bloom–Richardson system can be improved by reducing the 
cutoff for mitotic index and by counting 20–30 fields rather than 10 high-
power fields
45
. 
            Pinder et al analyzed histologic grade as a prognostic factor and as 
a indicator of response to chemotherapy in an International Breast Cancer 
Study Group trial involving 146 pateints
46
. The National Cancer Institute 
consensus conferences recognized that the essential factors in the  
treatment decisions for node-negative breast carcinoma were assessment 
of tumor grade and proliferative activity
.47
. 
          Histologic grade was reported to be the significant prognostic factor 
in the response of stage 2 patients to adjuvant chemotherapy
48
.It was also 
a indicator of treatment response among patients who receive endocrine 
treatment for systemic recurrence
49,5 
        Histologic grading should be done in formalin fixed paraffin 
embedded tissue sections. Delayed formalin fixation will affect the 
assessment of mitosis. 6 hour delay in fixation reduce the viable mitosis 
by 76%.The ideal fixative is 10% neutral phosphate buffered formalin 
(pH-7).The sections should be cut at 4-5 microns thickness. Conventional 
staining with haematoxylin and eosin is sufficient 
58
 
                    Grading is carried out in invasive carcinoma and not in in-situ 
component. Elston and Ellis 
51
 advocated grading  to all  histological  
types  of  Invasive  carcinoma  regardless  of  morphologic type and this 
practice have now gained general acceptance. Pure tubular,  Mucinous 
and cribriform carcinomas were graded as grade1.Medullary carcinoma 
was placed under grade 3 .Invasive lobular carcinomas were also graded 
using this  method. Pleomorphic variant of lobular carcinoma were 
graded as grade 3. Further, for some special types  such as mucinous and 
tubular  mixed  carcinoma , grading  provides a more appropriate 
evaluation of prognosis rather than the  histologic type. For mixed 
carcinoma, grading proved to be a better prognostic factor than typing 
alone
70.
The most widely accepted Nottingham modification of Scarff  
Bloom Richardson  grading system was used.They include 
• Tubule formation 
• Nuclear pleomorphism 
• Mitotic count 
 
TUBULE FORMATION: 
            Tubular structures are those with central lumen surrounded by 
polarized tumor cells. Solid clusters with reversal of polarity seen in 
micropapillary carcinoma should be scored 3 for tubule formation. All 
areas of the tumor should be scanned and the proportion of the tumor 
occupied by definitive tubular structures with central luminal space is 
assessed. Care should be taken not to mistake clefts induced by shrinkage 
for glands/tubule. 
NUCLEAR PLEOMORPHISM: 
        Assessment of nuclear pleomorphism is the most subjective element 
of histological grade. Fritz Rank et al states that criteria for nuclear 
pleomorphism includes irregularity in size, shape and staining of nuclei
52
. 
         Nuclear pleomorphism is a morphological measurement  of tumor  
differentiation  at the cytological  level and from the genetic point of 
view, it is a indirect measurement of aneuploidy and gentic instability.To 
establish the degree of objectivity, we use the size of normal epithelial 
cells in the adjacent breast tissue as a reference. When normal epithelial 
cells were not seen, stromal lymphoid cell is used as a reference for cell 
size and shape                       
 
MITOTIC COUNT: 
            They reflect the proliferative activity of the tumor and the most 
prognostically significant component of the grading system. Mitotic rate 
was reported to be the most important feature of Bloom Richardson 
grading system by Parham et al
53
.Jannink compared four methods for 
measuring mitoic activity and concluded that the traditional mitotic 
activity index was preferable
53
. In a study of these individual parameters, 
it has been concluded that the presence of mitotic activity is the strongest 
predictor of decreased survival.
 40
 
Van Deist et al offered a detailed specification for mitotic figures
54
 
Morphological criteria for mitotic figures:  
 Absent nuclear memberane 
 Clear hairy extension of the nuclear material, either 
clotted(beginning metaphase) in a plane (metaphase/ anaphase) 
or in separate clots (Telophase) 
 The surrounding cytoplasm should not be eosinophilic 
 Two parallel clearly separate chromosome clots should be 
counted as  seperate mitosis 
  Triangular or spiky nucleus with eosinophilic cytoplasm favours 
apoptosis. They indicate individual cell necrosis rather than proliferation 
The Nottingham modification excludes the hyperchromatic nuclei when 
this is the only mitosis related feature. Mitotic score depends on the 
number of mitosis per high power field. The size of the high power field 
should be standardized. 
            Variations in field size had the greatest effect on the scoring of 
mitotic counts when mitotic count per mm
2
 was between 7 and 20.As a 
method of overcoming this difficulty, a table has been created listing 
mitotic rates per 10 high per fields for different microscopes
71,72
 and a 
conversion factors have developed for converting counts per 10 high 
power field to counts per mm
73
 . Field areas ranges from 0.071mm
2 
to 
0.385mm
2 
with an objective of 40 X. An important variable in these 
calculations is the field number,or the index, a factor that varies among 
microscopes and can be obtained from manufacturer.  
           Kupio and collan demonstrated substantial variation of grading in 
Bloom Richardson system depending on field size and mitoic rate
55.
 A 
Minimum of 10 fields at the periphery of the tumor has to be counted. If 
there is variation in mitotic figures in different areas of the tumor, the 
least differentiated area should be taken into account. The preliminary 
assessment of the section should be carried out under low power to assess 
the least differentiated area. Start counting when one notices atleast one 
mitotic figure and then proceed to 10 consecutive non-overlapping fields 
            Robinson et al reported that grade 2 tumors comprise about 60 % 
of invasive breast Cancer
56
.Chabra et al reported that maximum number 
of cases as grade 2(52%) followed by grade 1(30%) and grade 
3(18%)
57
.Assesment of tubular differentiation is done on the overall 
apearence of the tumor whereas nuclear appearance including mitotic 
figure are evaluated on the least differentiated part of the tumor 
 OTHER PROGNOSTIC FACTORS: 
NECROSIS: 
     Tumor necrosis is defined as the presence of confluent necrosis of any 
dimension that could be distinguished at intermediate grade. Vischer et al 
support the view that widespread necrosis is a unfavourable feature in 
invasive duct carcinoma of breast 
APOPTOSIS: 
             Jonnsur et al observed bcl-2 observation expression in low grade 
tumors. Silverstrini et al 
76
shows that bcl-2 staining is in inversely related 
to proliferative activity. Most investigators reported that bcl-2             
immunoreactivity was in low grade tumors
74,75
.Zhang et al concluded that 
bcl-2 expression is a better response to hormone therapy and a favourable 
prognostic factor regardless of nodal status. 
 
EXTENT OF INTRAUCTAL CARCINOMA: 
            Silverberg and Chitale observed a trend of decreased nodal 
metastasis and favourable prognosis when intraductal carcinoma is 
extensive
77
.Recurrence occurs more often in breast after lumpectomy and 
radiation therapy in women who have comedo intraducatal carcinoma or 
when there is extensive intraductal carcinoma within and around an 
invasive tumor that comprises at least 25% of neoplasm.  
IMPACT OF NEOADJUVANT THERAPY ON PROGOSIS: 
                A Study of 372 pateints with locally advanced breast carcinoma 
found that 60 Patients had complete pathologic response after 
neoadjuvant therapy 
59
. Factors predictive of complete pathologic 
response were poorly differentiated nuclear grade, negative estrogen 
receptors, poorly differentiated histologic grade. The fundamental 
observation in treatment effect is a decrease in tumor cellularity. Rajan et 
al observed a decrease in tumor cellularity from 40% in pretreatment 
biopsies to 10% in tumor resected after chemotherapy
60
.In most extreme 
situation, no residual carcinoma may be detectable, an occurrence 
reported in 6.7%
61
 and 10% 
62
. 
          Healed sites of previously infiltrating carcinoma characterized by 
fibrosis, stromal edema, increased vascularity and chronic inflammatory 
cell infiltrate. Stromal elastosis may be prominent after treatment. Foci of 
intraductal carcinoma and lymphatic tumor emboli may be relatively 
resistant to treatment. This was supported by study by sharkey 
etal
63
.cytological alterations includes enlarged cells with increased 
cytoplasmic volume. The cytoplasm contains cytoplasmic vacuoles and 
eosinophilic granules.cell borders are well defined with shrinkage of cell 
from the stroma. Multinucleated giant cells and abnormal mitotic figures 
were seen.                   
        An analysis comparing the histologic grading in pre and post 
chemotherapy specimens did not reveal significant differences
82
 whereas 
some others reveal upgrading of tumor in 32% of cases
63
.Further it was 
concluded that grading of treated carcinomas may not be predictive of 
prognosis after therapy. 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
            This prospective study was carried out in 50 cases of  invasive 
duct carcinoma of breast for a period of one year from August 2011-july 
2012.This  study was done in department of pathology, Coimbatore 
medical college Hospital, Coimbatore. In all these cases the cytological 
diagnosis were confirmed by histological examination.   
 
INCLUSION CRITERIA: 
1. Female patients with palpable breast mass. 
2. Patients who were proved to have ductal carcinoma of breast by 
FNAC. 
3. Patients whose cytological diagnosis of Invasive duct carcinoma was 
confirmed in histological specimens 
4. Other special types of ductal carcinoma were also included.  
 
EXCLUSION CRITERIA : 
1. Known cases of invasive duct carcinoma of breast who have 
received chemotherapy or radiotherapy 
2. Patients those who do not have histological confirmation  
3. Male patients with ductal carcinoma of breast. 
4. Patients who underwent lumpectomy alone. 
 
DATA COLLECTION : 
  Female patients with palpable breast lesions were selected. 
Patients’ age, tumor location, tumor size as examined clinically were 
recorded. The patients were classified into three categories based on age  
1) Pre-menopausal(<47)   
2) Menopausal (47-52)  
3) Post-menopausal(>52). 
  The consent was obtained from the patient. 
FNA PROCEDURE: 
         The FNA Procedure was done by the Faculty and Postgraduates of  
Department of pathology, Coimbatore medical college using 23 gauge 
needle with or without 10 ml disposable syringe by non-aspiration 
technique. The aspirated material was expressed on slide, smeared and 
fixed with 95% alcohol for 20 minutes. These wet fixed slides were 
stained with Papanicolaou method and Haematoxylin and eosin. 
       The procedures of Papanicolaou and Haematoxylin and eosin stain 
were as follows: 
Papanicolaou stain: 
                               Fix in 95% Isopropyl alcohol-20 minutes 
                               80% Isopropylalcohol-1minute 
                               70% Isopropylalcohol -1 minute 
                               50% Isopropylalcohol -1 minute 
                               Rinse in water-10 minutes 
                               Harris haematoxylin-7 minutes 
                               Rinse in tap water-10 minutes 
                               Differentiate in 1% acid alcohol 
                               Blueing in tap water-10 minutes 
                               70% Isopropylalcohol  - 5 minute 
                               90% Isopropylalcohol - 5 minute 
                               OG-6        - 2 minutes 
                               95% Isopropylalcohol -1 minute 
                               95% Isopropylalcohol -1minute 
                               95% Isopropylalcohol -1 minute 
                               EA-50   -    4 minutes 
                               95% Isopropylalcohol -1 minute 
                               95% Isopropylalcohol-1 minute 
                               95% Isopropylalcohol -1 minute 
                               Xylene:Alcohol(1:1)-5 minutes 
                               Xylene- 10 minutes 
                               Mount with DPX     
The Procedure for Haematology and eosin stain in cytology: 
                            Fix in 100% isopropyl alcohol -20minutes 
                             Haematoxylin-15 minutes 
                             Rinse in tap water-10 minutes 
                             Eosin-7 dips 
                             Rinse in tap water 
                             Dry, Xylene and mount 
   The stained smears were evaluated and diagnosed as ductal carcinoma 
of breast when there is definite features of malignancy like cellular 
dissociation, nuclear pleomorphism, nuclear abnormalities, absence of 
bare nuclei. Any special variants of ductal carcinoma were also included. 
These slides were graded based on grading system proposed by 
Robinson. Those smears with suspicious cell clumps and features 
suggestive of ductal hyperplasia were excluded.  
 Robinson cytological grading system: 
            SCORE 1 SCORE 2 SCORE 3 
Cell 
Dissociation 
Mostly in clusters Single cells and clusters Mostly in single cells 
Nuclear size  1-2 times the size 
of RBC 
3-4 times the sizeof RBC >5 times the size of 
RBC 
Cell uniformity Monomorphic Mildly pleomorphic Pleomorphic 
Nucleoli Indistinct/small Noticeable Abnormal 
Nuclear margin Smooth Slightly 
irregular/folds/grooves 
Buds and clefts 
Chromatin 
pattern 
Vesicular Granular Clumping and 
clearing 
  
            The value between 1 and 3 is given for every factor analyzed. The 
sum of these values gives the total score. Total score ranges between 6 
and 18. According to which grading was done. 
              Grade 1: Score 6- 11 
              Grade 2: Score 12-14 
              Grade 3: Score 15-18 
          Modified radical mastectomy specimens including axillary 
clearance fixed in 10% formalin were obtained. The tumor size and the 
tumor location were assessed in the gross specimens. 
 Paraffin embedded sections obtained by routine procedures were 
cut at thickness of  3 microns using Leica microtome .These slides were 
routinely stained with haematoxylin and eosin stain.  
          The slides were evaluated and the diagnosis of invasive duct 
carcinoma was confirmed. Special types of ductal carcinoma other than 
classical invasive duct carcinoma NOS were also included in this study 
Histological grading was done using Nottingham modification of Scarff 
Bloom Richardson method. This system considers three parameters .They 
include tubule formation, nuclear pleomorphism and mitotic rate. 
 
Modified Bloom Richardson Histologic grading 
 1 2 3 
Tubule 
formation 
>75% 10-75% <10% 
Nuclear 
pleomorphism 
Small 
regular 
uniform 
cells 
Moderate 
increase in size 
and variability 
Marked 
variation 
Mitotic count <9 10-19 >20 
            
   Each parameter was assigned a score of 1 -3.Each score was added to 
give a total score of 3- 9. In the present study mitotic count was done in 
0.59mm field diameter Olympus microscope 24mm eyepiece with a 40x 
objective gives a field diameter of 24 ÷ 40 = 0.59mm .Number of mitosis 
were counted per 10 high power field. Mitotic counts .according to the 
field diameter were given in the appendix 2.According to the score they 
are graded. 
Grade 1:  Score 3-5 
Grade 2: Score 6-7 
Grade 3: Score 8-9 
         
The axillary lymph nodes received were also processed in a similar 
manner and assessed for metastasis. Statistical analysis was done to 
examine the degree of association between the cytologic and histologic 
grading system using Chi square test. Also the tumor grades were 
correlated with other prognostic factors which includes age of the patient, 
tumor size and lymph node status independently. The P value < 0.05 was 
considered to be statistically significant.  
 
 
 
                                         
 
                    
 
 
 
 
 OBSERVATIONS AND RESULTS 
Total of 50 cases were studied and the following observations were 
obtained. 
AGE DISTRIBUTION: 
 The patients age ranges from 32-86 years with a mean age of  
52.52 years. The minimum age and the maximum age reported in the 
present study was 32 and 86 years respectively. 
The patients age group were divided into three age groups 
         Table 1:Distribution of cases according to different age groups 
AGE GROUP NUMBER(%) 
PREMENOPEUSAL   (<47) 19(38%) 
MENOPAUSAL           (47-52) 9(18%) 
POSTMENOPAUSAL  (>52) 22(44%) 
 
 According to this table, majority of cases belong to the post 
menopausal age group (44%), 38% of case in premenopausal age group 
and the 18% of cases in the menopausal age group.  
    
 
Chart – 1:  Distribution of cases according to different age groups 
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TUMOR SIZE: 
       The cases were divided into three categories based on tumor size 
according to TNM staging
Table 2: Distribution of cases according to tumor size
 
   Of these fifty patients,four (8%) of them have tumor size <2cm.thirty( 
60%) patients have tumor size between 2 and 5 cm. sixteen(32%) of them 
have tumor size >5cm.
 Chart – 2: Distribution of cases 
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LYMPHNODE STATUS: 
      The lymph node status was classified into positive and negative nodes 
Table 3: Distribution of cases according to  lymph node status 
NODAL STATUS NUMBER OF CASES(%) 
NEGATIVE NODES 24(48%) 
POSITIVE NODES 26(52%) 
         Of the fifty cases, twenty four(48%) cases were node negative 
Among the  twenty six node positive cases, ten cases had 1-3nodes, 
fourteen cases had 4-9 nodes, two cases had more than 10 nodes. 
 Chart-3: Distribution of cases according to lymph node status 
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TUMOR LOCATION: 
       According to the location of the tumor, they have been classified into 
outer, inner and central quadrant   
Table 4:Distribution of cases according to the tumor location 
TUMOR LOCATION NUMBER OF CASES 
OUTER 25 (50%) 
INNER 10 (20%) 
CENTRAL I5 (30%) 
  In this study of fifty cases, majority of the cases were located in the 
outer quadrant (50%) followed by central quadrant tumors (30%) .20% of 
cases were located in the inner quadrant 
  Chart – 4: Distribution of cases according to the tumor location 
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CYTOLOGICAL GRADE: 
     According to Robinson grading system, the cytological samples were 
graded into three groups 
Table 5: Distribution of cases with regard to cytological grade 
CYTOLOGIC GRADE NUMBER 
GRADE 1 16(32%) 
GRADE 2 23(46%) 
GRADE 3 11(22%) 
            Of the fifty cases, majority of the cases belong to grade 2(46%) 
with 23 cases, next was grade 1(32%) with 16 cases followed by       
grade 3 (22% ) with 11 cases. Few special types were also reported .This 
includes mucinous carcinoma which was graded as grade 1,papillary 
carcinoma under grade 2.one of the grade 1 carcinoma show a uniform 
dispersed cells with plasmacytoid morphology. One of the ductal 
carcinoma with grade 2 nuclear features show plenty of lymphocytes in 
the background.  
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HISTOLOGICAL GRADE: 
           According to Nottingham modification of Scarff Bloom 
Richardson grading, fifty cases were categorized under three categories 
Table 6:Distribution of cases with regard to histological grade 
HISTOLOGIC GRADE NUMBER(%) 
GRADE 1 14(28%) 
GRADE 2 23(46%) 
GRADE 3 13(26%) 
 
 In this study of fifty cases, majority of tumors were grade 2 tumors 
with twenty three cases (46%),fourteen cases  were under grade 1(28%) 
and thirteen cases were classified as grade 3(26%).  
        Among these fifty cases, there were three special types of invasive 
duct carcinoma and the rest of the forty seven cases were Invasive duct 
carcinoma,NOS. The special types include mucinous carcinoma under 
grade 1, papillary carcinoma under grade 2, One of the grade 2 invasive 
ductal carcinoma NOS show neuroendocrine differentiation. One of the 
grade 3 ductal carcinoma diagnosed in cytologic samples as ductal 
carcinoma with plenty of lymphocytes in the background was diagnosed 
to be atypical medullary carcinoma.   
      Chart-6: Distribution of cases with regard to histological grade 
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CORRELATION OF CYTOLOGIC GRADE WITH HISTOLOGIC 
GRADE: 
               The cytological grade of the tumor was correlated to the 
histologic grade to assess the concordance between the two grading 
systems.                                                                     
Table 7:Correlation of cytologic grade with histologic grade  
 HISTOLOGIC GRADE TOTAL 
1 2 3 
 
CYTOLOGIC  
GRADE 
 
1 12(75%) (12.5%) (12.5%) 16 
2 
 
1(4.35%) 21(91.3%) 
 
1(4.35%) 23 
 
3 1(9.09%) 0 10(90.9%) 11 
    14 23 13 50 
 
CHI-SQUARE TOTAL = 60.04 DF = 4 Significant at 1% level (P<0.01) 
           In this study of fifty cases, forty three cases(86%) show 
concordance  between cytologic and histologic grading systems . Rest of 
the seven cases (14%) show discrepancy. Among the 16 grade 1 tumors, 
twelve cases (75%) show concordance with the histological grade 
whereas four cases were discordant. All these four cases were upgraded. 
Among the twenty three grade 2 tumors, two cases did not correlate, one 
was upgraded to grade 3 and the other was downgraded to grade 1.Rest of 
the twenty one grade 2 tumors show good concordance (91.3%).Grade 3 
tumors show good concordance with ten cases (90.9%).Only one of the 
grade 3 tumor was downgraded to grade 1.In this study  association 
between cytological grade and histological grade was statistically 
significant(p<0.01).  
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CORRELATION OF THE CYTOLOGICAL GRADE  WITH THE 
AGE OF THE PATEINT : 
The cytological grade was compared with the age of the patient            
Table 8:Correlation of cytological grade with the age of the patient 
CYTOLOGICAL 
GRADE 
           AGE OF THE PATEINT  TOTAL 
 <47 YRS 47-52 YRS >52 YRS  
GRADE 1 5(31.25%) 4(25%) 7(43.75%) 16 
GRADE 2 7(30.53%) 3(13.05%) 13(56.52%) 23 
GRADE 3 7(63.62%) 2(18.19%) 2(18.19%) 11 
 19 9 22 50 
 
CHI-SQUARE TOTAL = 5.68  DF = 4 Not Significant (P>0.05) 
       The above table represents the correlation of cytologic grade with the 
age of the patient. It shows that grade 3tumors was seen to occur in 
younger age group (63.62%) which indicates aggressiveness of tumor in 
young age group. The minimum age reported was 32 years who shows  
grade 3 in both cytology samples and histology specimen .The cytologic 
grade did not show a significant association with age of the 
patient(p>0.05).  
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CORRELATION OF CYTOLOGIC GRADE WITH TUMOR SIZE: 
      The cytologic grade was correlated with the tumor size to see whether 
high grade tumors were associated with large size tumors 
Table 9:Association between cytological grade and tumor size 
CYTOLOGIC 
GRADE 
TUMOR SIZE TOTAL 
 <2cm 2-5cm >5cm  
GRADE 1 2(12.5%) 9(56.25%) 5(31.25%) 16 
GRADE 2 2(8.7%) 13(56.52%) 8(34.78%) 23 
GRADE 3 0 8(72.72%) 3(27.28%) 11 
 4 30 16  
 
CHI-SQUARE TOTAL = 1.82  DF = 4 Not Significant (P>0.05)
 Most of the tumors  have a tumor size 2-5cm  with 56.25% in grade 
1,56.52% in grade 2 and 72.72% of grade 3 tumors respectively. The 
grade did not show a significant association with the tumor size (p>0.05) 
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CORRELATION OF CYTOLOGIC GRADE WITH LYMPHNODE 
STATUS: 
         The cytologic grade was correlated with the lymph node status to 
see whether high grade tumors were associated with increased lymph 
node positivity.  
Table 10:Correlation of cytologic grade with lymph node status 
CYTOLOGIC 
GRADE 
LYMPH NODE            
STATUS 
TOTAL 
 NEGATIVE 
NODES 
POSITVE 
NODES 
 
GRADE 1 10(62.5%) 6(37.5%) 16 
GRADE 2 11(47.83%) 12(52.17%) 23 
GRADE 3 3(27.8%) 8(72.7%) 11 
TOTAL 24 26 50 
 
CHI-SQUARE TOTAL = 3.24  DF = 2  Not significant (P>0.05) 
 All the lymph nodes mentioned here were axillary lymph nodes. 
No cervical and internal mammary nodes were obtained.Lymph node 
metastasis was observed in 6 of grade 1, 12 of grade 2 and 8 of grade 3 
tumors. Among the 16 cases of grade 1tumors 62.5% were node negative 
and only 37.5% were node positive. In contrast 72.7% and 52.17% of 
grade 3 and grade 2 were node positive respectively. Most of the tumors 
with more than four positive lymphnodes were grade 3 tumors. None of 
the grade 1 tumors had metastasis in more than 10 nodes. In the present 
study the association between cytological grade and lymph node status 
was not significant(p>0.05).  
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CORRELATION OF CYTOLOGICAL GRADE WITH THE 
TUMOR LOCATION 
Table 11:Correlation of cytologic grade with the tumor location 
CYTOLOGIC 
GRADE 
TUMOR LOCATION TOTAL 
 OUTER CENTRAL INNER  
GRADE 1 10(62.5%) 3(18.75%) 3(18.75%) 16 
GRADE 2 11(47.82%) 6(26.09%) 6(26.09%) 23 
GRADE 3 4(36.37%) 6(54.54%) 1(9.09%) 11 
 25 15 10  
               
           Out of the fifty cases, most of grade 1 and grade 2 tumors were in 
outer quadrant with 62.5% and 47.82% respectively whereas most of 
grade 3 tumors were I the central quadrant(54.54%). 
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CORRELATION OF LYMPH NODE STATUS WITH TUMOR 
SIZE : 
 The lymph node status was correlated with the tumor size to see 
whether increase in tumor size was associated with increase in lymph 
node positivity.  
Table 12:Association between lymph node status and tumor size 
LYMPHNODE 
STATUS 
TUMOR SIZE TOTAL 
 <2cm 2-5 cm >5cm  
NEGATIVE 
NODES 
3(12.5%) 17(70.83%) 4(16.67%) 24 
POSITIVE 
NODES 
1(3.85%) 13(50%) 12(46.15%) 26 
TOTAL 4 30 16  
 
CHI-SQUARE TOTAL = 6.62 DF = 6 Not Significant (P>0.05)  
 This Table indicates that most of the tumors with positive lymph 
nodes have a size between 2-5 cm .Maximum numberof positive nodes 
was reported to be 18 and 15 and corresponding tumor size were 8.5and 7 
cm respectively. In Mucinous carcinoma ,though the size was >10 cm all 
the twelve nodes were negative indicating a favourable prognosis .There 
was no significant association between the tumor size and lymphnode 
status(p>o.05).  
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CORRELATON OF TUMOR LOCATION WITH LYMPH NODE 
STATUS: 
        The lymph node status of the tumor was correlated with the tumor 
location to see whether the tumor in a particular location has more 
predilection for lymph node positivity 
 
Table 13:Correlation of tumor location with lymph node status 
TUMOR 
LOCATION 
LYMPH NODE            
STATUS 
TOTAL 
 
NEGATIVE 
NODES 
POSITVE 
NODES 
 
OUTER 11(44%) 14(56%) 25 
CENTRAL 9(60%) 6(40%) 15 
INNER 4(40%) 6(60%) 10 
TOTAL 24 26 50 
 
 This table indicates that 56% of outer quadrant tumors, 40% of 
central quadrant tumors and 60% of inner quadrant tumors were node 
positive.  
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                  Fig 3: Malignant cell is 1-2 times the size of RBC (FNAC-H&E) 40 X 
  
Fig 4: Tumor show >75% tubule formation (HPE-H&E) 10X. 
                               
                              
Fig 5:  Small nuclei showing mild pleomorphism with regular nuclear membrane                         
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Fig 6: Malignant epithelial cells arranged singly and in clusters with mild 
pleomorphism  ( FNAC
                                    
                               
Fig 7: Noticeable nucleoli with granular chromatin (FNAC
-Pap stain) 10X 
-Pap) 40 X
 
 
 
Fig 8: Nuclear membrane shows irregularity with folds (arrow) 
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Fig 9: Tumor shows few tubules
H&E)10X.
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          Fig 10:Malignant
                              
                                     
Fig 11: Marked nuclear pleomorphism with prominent nucleoli
 epithelial cells arranged singly
(FNAC-Pap stain)10X 
               
(FNAC-Pap) 40X 
 
 
 
 
 
Fig 12:Nucleus
                              Fig 13:Tumor arranged in solid sheets(HPE
                      
                                             
 showing bud and clefts. Inset shows clumped 
nuclear chromatin(FNAC-Pap stain) 40 X
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     Fig 15:  Lymphovascular inva
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Fig 14:Large pleomorphic cells with prominent nucleoli
Inset shows three mitotic figures in one field 
40X 
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Fig 16: Tumor cells in a background of mucin (FNAC
                                    
Fig 17:Cells arranged singly with moderate atypia in a 
background of mucin(FNAC
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  Fig 18: Gross 
surface 
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Fig 19: Nest of tumor cells in a pool of extracellular mucinwith 
small dark nucl
- Well circumscribed mass with glistening cut 
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 Fig 20: Branching papillae with fibrovascular core lined by 
Fig 21: Papillae lined with tall columnar cells with nuclear 
           
atypical epithelial cells (FNAC-H&E) 
stratification and atypia  (FNAC-H&E)
 
 
 
 
                       Fig 22: Papillary structures with fibrovascular core
H&E)10 X 
                            
Fig 23: Papillae lined by multilayered atypical epithelial cells with 
moderate  nuclear pleomorphism (HPE-H&E) 40X
 
 (HPE-
 
 
                                             
                              Fig 24: Malignant cell cluster with moderate pleomorphism in  
a background of 
                                             
        
                                       
                      
  
scattered lymphocytes (FNAC-H&E) 40X
 
 
 
 
 
 
 
 
 
 
Fig 25:Syncytium of tumor cells surrounded by 
lymphoplasmacytic infiltrate(HPE- H&E) 10X
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Fig 26:Synctium of tumor cells with moderate nuclear 
 (arrow) 
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DISCUSSION 
               Breast carcinoma is a malignant disease with a variable 
prognosis. Assessment of prognostic parameters is of growing interest in 
recent days. The parameters consist of tumor size, lymph node status,
 
28
estrogen receptor status,
 29
  histological grading
 27
 and cell proliferation 
index
 30.
All these features have been well studied on surgical specimens, 
however evaluation of prognostic factors and grading of cytologic 
samples have not been included in the routine practice. Cytologic grading 
is valuable, feasible and reproducible
26,16
.This method also depicts the 
intrinsic characteristics of the tumor as well as its prognosis
20
.
 
 
               The need for prognostic grading in cytological samples of  
breast cancers is to identify rapidly growing tumors (grade III), which 
were more responsive to chemotherapy and better suited to pre-treatment 
with tamoxifen. Overtreatment of slow growing tumors was also reduced. 
Assessment of biological aggressiveness by cytological grading without 
removing the tumor would therefore be of immense value
15
. 
                          
In
 
this present study predominant tumors were grade 2 (46%) 
followed by grade1 (32%) and grade 3 (22%) in cytological samples. A 
study by Robles et al
67
 showed a similar result, the predominant tumors 
were grade 2 (39%) followed by grade 1(36%) and then grade 3(25%). 
Studies done by Dash et al
14
, Chabbra et al
57
, Robinson et al
56 
also 
showed similar results. However in a study by Wani et al 
18
grade 3 forms 
the second largest group as against to grade 1 in this study. This shows 
the increasing awareness and early presentation of the patients in our 
setup.  
           This study showed a high degree of concordance (86%)) between 
the cytological and histological grading systems. Khan et al
20
 and 
Nijahawan et al
9
 showed a concordance value of 84% and 82.5% 
respectively. A study by Milentijevic et al
7
 also show a concordance 
value of 81%.High concordance value were also found by Taniguchi et 
al
16
  Chabbra et al
57
 and Bhargava et al
74
 .Concordance between cytologic 
and histologic grading was observed more frequently in purely invasive 
carcinomas (85%)
6
. This study was close to these studies. However Dash 
et al
14
, Moriquand et al and Gayathri et al
5
 showed concordance of 
77.5%.Sinha et al showed a concordance rate of 69.5% . 
                 Low concordance in these studies was probably due to the 
inclusion of patients receiving chemotherapy and inclusion of cases 
diagnosed as atypical ductal hyperplasia and insitu carcinomas in 
cytological samples. In the present study the patients receiving 
neoadjuvant chemotherapy were excluded and only cases showing 
definitive features of ductal carcinoma in both cytology samples and 
histologic specimens were included. This explains the high concordance 
between the grading systems.  
         In this study, association between cytological grading and 
histological grading system was highest among grade 2 tumors (91.3%) 
followed by grade 3(90.9%) and least with grade 1(75%). Sinha et al
4
 
states that grade 3 tumors showed a greater concordance. Jayaram et al
11
 
states that concordance was found to be higher among grade 3 tumors 
(83.3%) and low among grade 1 tumors (75%).These studies coincides 
with the present study. Khan et al
20
 states that higher concordance was 
found among grade1 tumors(92.3%).Several studies states that 
concordance was high among high grade tumors. The present study also 
supports this view. Out of the seven discordant cases, four of grade 1 
tumors were upgraded. Among two discordant grade 2 tumors, one was 
upgraded to grade 3 and other was downgraded to grade1.The one 
discordant grade 3 tumor was downgraded. The reason for the upgrading 
of tumors may be due to sampling errors in large size tumors and 
hetrogenous tumors. As orientation of the tumor cannot be made more 
accurate clinically, multiple passes in FNAC were aimed at the central 
portion of the tumor neglecting the active periphery. In histologic 
specimens the infiltrating edge of the tumor was correctly assessed and 
multiple blocks were made from that site to assess the grade. Another 
reason of the upgrading of tumors may be due to inadequate samples. The 
low percentage of concordance in grade1tumors was due to the fact that 
these low grade tumors goes for a higher grade in the time lag between 
FNAC procedure and mastectomy,if there is long time gap between the 
two procedures. One of the reasons for downgrading of tumors may be 
due to the fact that only nuclear features were taken into consideration, 
while grading the cytologic samples. Tubule formation and mitotic count 
were not included. There may be subjective variability among the 
observers which explains the discrepencies.  
        Regarding the association between the cytological grade and lymph 
node status, node positivity was seen in 37.5%, 52.17% and 72.7% of 
grade 1, 2 and 3 tumors respectively. In a study by Khan et al
20
 lymph 
node metastasis were seen in 15.4% of grade 1, 55.6% of grade 2 and 
83.3% of grade 3 tumors. Most of tumors in the present study with more 
than four positive lymphnodes were grade 3 tumors.In a study by Robles 
et al 
67
lymph node metastasis was observed in 8.3% of grade 1, 64.1% of 
grade 2 and 88% of grade 3 tumors. In a study by Dash et al
14
 74.2% of 
grade 3 tumors showed nodal metastasis in contrast to 27% in grade 1 
tumors. Our study correlates more with the study by Dash et al
14
.The 
association between the cytological grading and lymphnode status was 
not statistically significant (p>0.05).When this association had been 
proved, level of resection can be assessed preoperatively by the 
cytological grade itself. But in this study cytologic grade did not correlate 
with axillary lymph nodes status .This is because in this study, criteria for 
the minimum number of nodes to be examined was not been defined. 
When the minimum number of nodes to be examined was increased to 10 
nodes, better association can be obtained.   
         Other demographic factors like age and morphological factors like 
tumor size and tumor location were also studied .Regarding the age of the 
patient,most of the tumors were in the post-menopausal age 
group(52%).The mean age of presentation was 52.5 years. Most of grade 
3 tumors were in the premenopausal age group accounting for 63.3% 
indicating its aggressiveness in the young age group. This evidence was 
supported by Pratap et al
3
, Gann et al
1
 and Gayathri et al
5
.However the 
age of the patient did not correlate with the cytological grade statistically 
(p>0.05).  
       Regarding the tumor size majority of tumors (60%) were T2 tumors 
(2-5cm, TNM staging) .Since the size of the tumor was an independent 
time dependent prognostic factor, an attempt was made to correlate  
tumor size  with the cytological grade. No statistical significance was 
obtained (p>0.05).Similar results were observed in a study by Kim et al
28
, 
Gann et al
1
 and Gayathri et al
5
. 
          Numerous studies have shown survival decreases with increasing 
tumor size and coincidental increase in axillary node positivity
29
. Roger et 
al reported significant distribution of frequency of axillary lymph node  
involvement in relation to tumor size. But in our study there is no 
significant correlation between tumor size and lymph node 
status(p>0.05). 
        Regarding tumor location most of the tumors were located in outer 
quadrant accounting for 50%. However most of the grade 3 tumors were 
located in the central quadrant with 54.54%.A study by Harzah et al
15
 
shows that tumors in periareolar location are associated with poor 
prognosis. In the present study, tumors located in the inner quadrant 
(60%) show more lymph node positivity than other quadrant tumors.This 
is in contrast to all other studies where inner quadrant tumors show lower 
rate of lymph node positivity
1,5
. Similar to the present study Reger et al 
also showed no correlation between the tumor location and lymh node 
status.  
 
 
 
 
SUMMARY 
          Breast carcinoma is the second most common cause of cancer 
related deaths among female next to cervical cancer. In some cities, the 
incidence of breast cancer has been increasing. Invasive duct carcinoma 
is the most common malignancy of breast, accounting for 70-80%. 
Cytological evaluation of aspirates for early diagnosis and 
prognostication of breast malignancies is important to study the intrinsic 
feature and biologic aggressiveness of the tumor while the tumor is still in 
vivo. Among the various prognostic factors, nuclear grading is the most 
feasible, cost effective and can be done if proper staining techniques and 
qualified pathologist are available. No sophisticated instruments and 
laborious work is needed.  
        As FNAC is done as a baseline investigation that can be done on 
outpatient basis, a number of studies have attempted to grade the 
cytological samples. Cytologic grading of breast cancer is not well 
established despite histologic grading having gained a strong foothold. So 
attempt had been made to correlate the cytologic grading with well 
established Nottingham modification of Scarff Bloom Richardson 
grading. The cytological grade was also correlated with other prognostic 
factors like age,tumor size and lymph node status. 
          A study was done on fifty cases of ductal carcinoma where 
cytological diagnosis of Invasive ductal carcinoma was confirmed by 
histology. Pateints who had underwent preoperative neo adjuvant 
chemotherapy was excluded . Cytological samples were stained using 
H&E stain and Papanicolaou stain. Cytologic grading was done by 
Robinson method and compared with histologic grading system .The 
conclusion made were  
1. Most of the tumors were grade 2 tumors(46%) 
2. The concordance between cytological grade and histological grade 
was 86%, nearly 43 out of 50 cases 
3. The remaining 7 cases (14%) showed discrepancy. Among these 
cases five were upgraded and two were downgraded. 
4. The association between cytological grade and histological grade 
were statistically significant (p<0.05)      
5. Most common age of presentation was postmenopausal age group 
(52%) 
6.  However the grade 3 tumors was high among premenopausal age  
 Group (63.3%) 
7. The association between the age of the patient and the cytological 
grade was  not statistically significant(p>0.05) 
 8. The Lymph node positivity was noted among 37.5%, 52.17%, 
72.7% of grade 1, 2 and 3 tumors respectively. High grade tumors 
show increased nodal positivity.  
9. The association between cytological grade and lymphnode status 
was not statistically significant (p>0.05) 
10. Most of the tumors were T2 (2-5 cm).The association between 
tumor size and cytologic grade was not statistically significant 
(p>0.05).The association between tumor size and lymph node status  
was also not significant(p>0.05) 
11. Most of the tumors were located in outer quadrant 50%.most of 
grade 3 tumors were located in the central quadrant. Tumors 
located in the inner quadrant show a increased nodal postivity(60%) 
 
  
            This concludes that cytological grading should be included in  all  
FNAC reports of ductal carcinoma of breast, so  that appropriate decision 
can be made regarding the neoadjuvant chemotherapy can be taken and 
overtreatment of low grade carcinomas can be avoided. Preoperative 
grading of breast cancer helps the surgeons to plan the type of operation 
and level of lymph node resection. This suggest the use of nuclear 
morphometry to increase the accuracy and reduce the observer variability.  
 
                               
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 Due to the Increasing incidence of breast cancer in recent years, the 
role of FNAC in the early identification of breast cancer has been 
tremendously increased. This present study evaluates prognostic factors 
in cytological samples .Of the various prognostic factors, cytological 
grading is the one which is more feasible and reproducible.The  
histological grade is one of the well known morphological prognostic 
factor and had been included in all reports of breast malignancies. This 
study shows a significant correlation between the cytologic grade and 
histologic grade. This indicates that cytological grade predicts the tumor 
aggressiveness.  
        So it was concluded that the cytological grading should be included 
in all FNAC reports. So that appropriate decision regarding the 
preoperative neoadjuvant chemotherapy can be made and overtreatment  
of low grade cancers has been avoided. In this study cytological grading 
did not correlate with the lymphnode status .When this correlation has 
been proved ,the level of lymph node resection can be planned 
preoperatively .Inspite of adequate efforts made to reduce the distortion 
in estimates, there is some degree of measurement bias and interobserver 
variability in this grading system.   
 
         This present study suggests the use of ancillary techniques like 
nuclear morphometry, immunohistochemistry for hormone receptors and 
proliferative indices done on cytological samples for further evaluation 
the tumor biology and aggressiveness.  
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                                           ANNEXURE-I 
 
                                               PROFOMA 
                                                                             
Name:                                                                      Age: 
Ward:                                                                       IP/OP No: 
Address: 
Presenting complaints: 
            Breast lump  
            Pain  
            Nipple discharge 
            Skin ulceration 
Duration of presenting complaint: 
Past history: 
            History of previous surgeries for breast lump 
            History of chemotherapy/Radiotherapy 
            History of breast lump in other breast 
Family history: 
 Personal history 
             Diet 
             Menstural history 
            Breast feeding history 
 
 
 
 
 
General examination 
            Nourishment :                                 Built:                    Consious: 
             Pallor:          Jaundice:           Cyanosis:         Clubbing: 
             PR:             RR:             BP:                     Febrile/afebrile: 
             Lymphadenopathy:                        Edema: 
            
Local examination of the breast 
             Side:Right/Left 
             Quadrant:upper/outer/inner/lower/cental 
             Size of the tumor: 
             Fixity to skin:yes/no                             Fixity to underlying 
fascia:yes/no 
Examination of axillary lymph nodes: 
               Number of nodes: 
               Mobile/fixed: 
               Size: 
               Group of nodes:Anterior/posterior/lateral/apical 
Cytological diagnosis: 
Any special type:yes/no 
Cytological grading 
            Cell Dissociation:1/2/3 
             Nuclear size: 1/2/3 
            Cell uniformity: 1/2/3 
             Nucleoli: 1/2/3 
           Nuclear margin: 1/2/3 
           Chromatin pattern:1/2/3 
Cytological grade:I/II/III 
Gross examination of modified radical mastectomy specimen 
             Size of the specimen including skin ,nipple &areola: 
             Size of the tumor:<2cm/2-5cm/>5cm 
              Margins:infiltrative/circumscribed 
              Quadrant:outer/inner/central 
 
Histologic diagnosis: 
Any special type: 
Lymph node status:no:of positive nodes/no:of total nodes examined 
Histologic grading 
                      Tubule formation:1/2/3 
                      Nuclear pleomorphism:1/2/3 
                       Mitotis:1/2/3 
Histoloigic grade:I/II/III 
               
 
 
 
 
 
 
 
 
 
  
ANNEXURE-II 
CONSENT  FORM 
 
The doctor has explained that, I (name of the patient)…………………, 
have a lump in my…………(side) breast/s  and that FNAC is proposed 
for the purpose of diagnosis. I understand the complications and thereby I 
agree for this procedure. 
 
 
 
 
 
 
 
 
SIGNATURE 
 
  
ANNEXURE-III 
POINTS FOR MITOTIC COUNTS CORRESPONDING TO MICROSCOPC 
FIELD AREA. 
FIELD 
DIAMETER NUMBER OF MITOSIS 
 
SCORE 1 SCORE 2 SCORE 3 
0.4 upto 4 5to8 9or more 
0.41 upto 4 5to9 10 or more 
0.42 upto 4 5 to 9 10 or more 
0.43 upto 4 5 to 10 11 or more 
0.44 upto 5 6 to 10 11or more 
0.45  upto 5 6 to11 12 or more 
0.46 upto 5 6  to 11 12 or more 
0.47 upto 5 6 to 12  13 or more 
0.48 upto 6 7 to12 13 0r more 
0.49 upto 6 7 to13 14 or more 
0.5 upto 6 7 to 13 14 or more 
0.51 upto 6 7 to14 15 or more 
0.52 upto 7 8 to 14 15 or more 
0.53 upto 7 8 to15 16 or more 
0.54 upto 7 8 to 16 17 or more 
0.55 upto 8 9 to 16 17 or more 
0.56 upto 8 9 to 17 18 or more 
0.57 upto 8 9 to 17 18 or more 
0.58 upto 9 10 to 18 19 or more 
0.59 upto 9 10 to 19 20 or more 
0.6 upto 9 10 to 19 20 or more 
0.61 upto 9 10 to20 21 or more 
0.62 upto10 11 to21 22 or more 
0.63 upto 10 11 to21 22 or more 
0.64 upto11 12 to22 23 or more 
0.65 upto 11 12 to23 24 or more 
0.66 upto 11 12 to 24 25 or more 
0.67 upto 12 13 to25 26 or more 
0.68 upto 12 13 to 25 26 or more 
0.69 upto 12 13 to26 27 or more 
0.7 upto 13 14 to 27 28 or more 
S.NO HPE NO FNAC NO AGE TUMOR 
SIZE 
TUMOR 
LOCATION 
CYTOLOGIC CYTOLOGIC 
GRADE 
HISTOLOGIC 
DIAGNOSIS 
HISTOLOGIC 
GRADE 
LYMPHNODE 
STATUS 
          DIAGNOSIS         
1 2285/11 F1003/11 65 6.5cm Outer DC Grade1 IDC NOS Grade 2 0 
2 2696/11 FI318/11 54 7cm Outer   Grade 2 IDC NOS Grade 2 2 
3 2697/11 F1944/11 40 3.5cm Central DC  with 
lymphocytes 
Grade 3 Atypical 
medullary 
carcinoma 
Grade 3 0 
4 2768/11 F1984/11 55 2cm Outer DC Grade 2 IDC NOS Grade 2 2 
5 2809/11 F2019/11 70 2.5cm Outer   Grade 1 IDC NOS Grade 1 5 
6 2859/11 F1087/11 60 7cm Outer DC Grade 3 IDC NOS Grade 3 4 
7 2866/11 F851/11 65 6.5cm Inner DC Grade 2  IDC NOS Grade 2 8 
8 2895/11 F2020/11 70 5cm Outer DC Grade 1 IDC NOS Grade 1 0 
9 2075/11 F1121/11 44 6cm Inner DC Grade 1 IDC NOS Grade 3 5 
10 2188/11 F1630/11 47 4cm Inner DC Grade 1 IDC NOS Grade 1 0 
11 1994/11 F1491/11 45 3cm Central DC Grade 1 IDC NOS Grade 1 0 
12 1978/11 F1329/11 44 3.5cm Outer DC Grade 2 IDC NOS Grade 2 1 
13 1977/11 F159/11 56 3cm Outer DC Grade 2 IDC NOS Grade 2 0 
14 1942/11 F1442/11 45 4cm Outer DC Grade 1 IDC NOS Grade 1 0 
15 2269/11 F1618/11 32 3.5cm Central DC Grade 3 IDC NOS Grade 3 0 
                  
                  
16 2923/11 F1316/11 49 3.5cm Central DC Grade 1 IDC NOS Grade 2 4 
17 12-Mar F1764/11 42 3cm Outer DC Grade 3 IDC NOS  Grade 3 8 
18 43/12 F2145/12 52 2.2cm Outer DC Grade 1 IDC NOS Grade 3 0 
19 75/12 F03/12 46 4.2cm Outer DC Grade 1 IDC NOS Grade 1 0 
20 967/12 F1158/12 55 1.7cm Inner Papillary 
carcinoma 
Grade 2 Papillary 
carcinoma 
Grade 2 0 
21 170/12 F2264/12 65 1.8cm Outer DC Grade 2 IDC NOS Grade 2 1 
22 186/12 F87/12 58 10cm Outer Mucinous 
carcinoma 
Grade 1 Mucinous 
carcinoma 
Grade 1 0 
23 237/12 F114/12 51 7cm Outer DC Grade 2 IDC NOS Grade 3 6 
24 253/12 F126/12 40 7.5cm Outer DC Grade 3 IDC NOS Grade 3 7 
25 304/12 F204/12 55 3cm Inner DC Grade 2 IDC NOS Grade 2 2 
26 321/12 F100/12 59 1.9cm Outer DC Grade 1 IDC NOS Grade 1 0 
27 435/12 F136/12 38 2cm Outer DC Grade 2 IDC NOS Grade 1 4 
28 436/12 F1923/11 65 8cm Outer DC Grade 1 IDC NOS Grade 1 0 
29 453/12 F120/12 46 5cm Central DC Grade2 IDC NOS Grade 2 0 
30 477/12 F886/12 56 8.5cm central DC Grade 3 IDC NOS Grade 3 3 
31 536/12 F125/12 40 1.5cm Inner DC Grade 2 IDC NOS Grade 2 0 
32 547/12 F2030/11 53 5.3 cm Outer DC Grade 2 IDC NOS Grade 2 5 
33 548/12 F248/12 56 3cm central DC Grade 2 IDC NOS Grade  2 3 
34 570/12 F78/12 39 8.5cm central DC Grade 3 IDC NOS Grade 3 18 
35 584/12 F264/12 43 8.2cm Central DC Grade 2 IDC NOS Grade 2 1 
36 643/12 F382/12 56 4cm Central DC Grade 2 IDC NOS Grade2 0 
37 716/12 F450/12 40 4.5cm Outer DC Grade 2 IDC NOS Grade 2 9 
38 717/12 F399/12 50 3.5cm central DC Grade  2 IDC NOS Grade 2 0 
39 774/12 F393/12 50 5.5cm central DC Grade 3 IDC NOS Grade 3 5 
40 775/12 F2085/12 65 4cm Inner DC Grade 1 IDC NOS Grade 1 0 
41 830/12 F446/12 50 4cm central DC Grade 1 IDC NOS Grade 1 0 
42 848/12 F54/12 70 4cm central DC Grade 3 IDC NOS Grade 1 0 
43 849/12 F530/12 86 4.5cm central DC Grade 2 IDC NOS Grade 2 0 
44 850/12 F182/12 56 3.5cm Outer DC Grade 2 IDC NOS Grade2 0 
45 851/12 F54/12 50 4.5cm Outer DC Grade 3 IDC NOS Grade 3 0 
46 906/12 F506/12 37 9.5cm Inner DC Grade 2 IDC NOS Grade 2 2 
47 1136/12 F648/12 42 5cm Outer DC Grade 3 IDC NOS Grade 3 7 
48 1147/12 F703/12 42 4cm Inner DC Grade 2 IDC NOS Grade2 2 
49 1204/12 F757/12 39 6cm Outer DC Grade 1 IDC NOS Grade 1 3 
50 1211/12 F846/12 54 4cm Inner DC Grade 2 IDC NOS Grade 2 3 
           KEY TO MASTER CHART 
 IDC NOS-Invasive duct carcinoma no special type 
 DC-Ductal carcinoma 
 
ABSTRACT 
      
          Fine needle aspiration cytology is the diagnostic tool used in the early 
detection of breast cancer.It is a valuable method to assess the behavior of the 
tumor while it is still in vivo. However cytological grading system is not well 
established as like histological grading.In the present study, fifty cases  of Invasive 
duct carcinoma  including certain special types like mucinous carcinoma, papillary 
carcinoma and atypical medullary carcinoma were analyzed. Cytological smears 
were graded using Robinson grading system and correlated with the well known 
histological grading as per Scarff bloom Richardson grading system .Cytological 
grading system was also correlated with other prognostic factors like age, tumor 
size and lymph node status. This grading system predicts the prognosis from fine 
needle aspirates and helps the surgeon to plan for further treatment. 
KEY WORDS:Invasive duct carcinoma NOS,FNAC,Robinson grading system  
